FDA NDC
XEMBIFY
This name is from the loaded FDA file.
Source: FDA NDC Directory, live from openFDA. Publisher page
- NDC
- 13533-810
- Proprietary name
- XEMBIFY
- Nonproprietary name
- immune globulin subcutaneous, human-klhw
- Labeler
- GRIFOLS USA, LLC
- Dosage form
- SOLUTION
- Strength
- 200 mg/mL
HCPCS J1561 Billable units per 11-digit NDC: 80.
Run it in Rivvi
Which 2027 plans near you dropped or restricted immune globulin subcutaneous, human-klhw?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan, from the CMS Part D files.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.